During the past decade, Northwest Arkansas Retina Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Northwest Arkansas Retina Associates" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Age-Related Macular Degeneration" (1 trials), "Macular Degeneration" (1 trials) and "Wet Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Northwest Arkansas Retina Associates" in a lesser frequency.

Most popular intervention types in "Northwest Arkansas Retina Associates" are "Other" (7 trials), "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Aflibercept" (4 trials), "KSI-301" (3 trials), "No intervention" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Arkansas Retina Associates" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Arkansas Retina Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northwest Arkansas Retina Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Arkansas Retina Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".